Business ❯ Healthcare ❯ Pharmaceuticals

Biotechnology

Acquisitions Clinical Trials Cell Therapies Pacira BioSciences Cancer Treatment Female Founders Engineering Solutions Market Competition Neumora Therapeutics Alzheimer's Disease Company Development Merck & Co., Inc. Regeneron Pharmaceuticals Moderna Innovent Biologics Avalo Therapeutics Biotech Companies Biocon Ltd Cancer Treatments Oncology Cell Therapy mRNA Manufacturing Ultragenyx Pharmaceutical Obesity Treatments Biogen

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

The companies expect to close in the second half of 2026 pending required approvals.

Ultragenyx Hit With Securities Class Action Over Failed Phase III Trials

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

Lilly and Innovent Forge Territory-Split Cancer and Immunology Alliance

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Pfizer Sues Metsera and Novo Nordisk to Block Termination of $4.9 Billion Deal

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio